...[In] response to the announcement that 11 Latin American countries have reached an agreement with 26 pharmaceutical companies, including Abbott Laboratories, GlaxoSmithKline, Merck, Bristol-Myers Squibb, Roche and Bayer to reduce the cost of life-saving anti-retroviral (ARV) drugs... "The cost of branded AIDS drugs is so high to begin with that the discounts announced today are not nearly deep enough to provide access to life-saving anti-retroviral medicines to all those who need them in these Latin American countries..." said Michael Weinstein, President, AIDS Healthcare Foundation (AHF)...